Skip to main content

Advertisement

Log in

The frequency and distribution of thiopurine S-methyltransferase alleles in south Iranian population

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Thiopurine methyltransferase (TPMT) catalyzes the S-methylation of thiopurine drugs such as 6-mercaptopurine, 6-thioguanine, and azathiopurine. Variability in TPMT activity is mainly due to genetic polymorphism. The frequency of the four allelic variants of the TPMT gene, TPMT*2 (G238C), TPMT*3A (G460A and A719G), TPMT*3B (G460A) and TPMT*3C (A719G) were determined in an Iranian population from south of Iran (n = 500), using polymerase chain reaction (PCR)-RFLP and allele-specific PCR-based assays. Four hundred seventy four persons (94.8%) were homozygous for the wild type allele (TPMT*1/*1) and twenty five people were TPMT*1/*3C (5%). One patient was found to be heterozygous in terms TPMT*1 and *2 alleles with genotype of TPMT*1/*2 (0.2%). None of the participants had both defective alleles. The TPMT*3C and *2 were the only variant alleles observed in this population. The total frequency of variant alleles was 2.6% and the wild type allele frequency was 97.4%. The TPMT*3B and *3A alleles were not detected. Distributions of TPMT genotype and allele frequency in Iranian populations are different from the genetic profile found among Caucasian or Asian populations. Our findings also revealed inter-ethnic differences in TPMT frequencies between different parts of Iran. This view may help clinicians to choose an appropriate strategy for thiopurine drugs and reduce adverse drug reactions such as bone marrow suppression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Van Loon JA, Weinshilboum RM (1982) Thiopurine methyltransferase biochemical genetics: human lymphocyte activity. Biochem Genet 20(7–8):637–658

    Article  PubMed  Google Scholar 

  2. Szumlanski CL, Honchel R, Scott MC, Weinshilboum RM (1992) Human liver thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isozyme. Pharmacogenetics 2(4):148–159

    Article  PubMed  CAS  Google Scholar 

  3. McLeod HL, Relling MV, Liu Q, Pui CH, Evans WE (1995) Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemia. Blood 85(7):1897–1902

    PubMed  CAS  Google Scholar 

  4. Szumlanski C, Otterness D, Her C, Lee D, Brandriff B, Kelsell D, Spurr N, Lennard L, Wieben E, Weinshilboum R (1996) Thiopurine methyltransferase pharmacogenetics: human gene cloning and characterization of a common polymorphism. DNA Cell Biol 15(1):17–30

    Article  PubMed  CAS  Google Scholar 

  5. Hamdan-Khalil R, Allorge D, Lo-Guidice JM, Cauffiez C, Chevalier D, Spire C, Houdret N, Libersa C, Lhermitte M, Colombel JF, Gala JL, Broly F (2003) In vitro characterization of four novel non-functional variants of the thiopurine S-methyltransferase. Biochem Biophys Res Commun 309(4):1005–1010

    Article  PubMed  CAS  Google Scholar 

  6. Hamdan-Khalil R, Gala JL, Allorge D, Lo-Guidice JM, Horsmans Y, Houdret N, Broly F (2005) Identification and functional analysis of two rare allelic variants of the thiopurine S-methyltransferase gene, TPMT*16 and TPMT*19. Biochem Pharmacol 69(3):525–529

    Article  PubMed  CAS  Google Scholar 

  7. Schaeffeler E, Eichelbaum M, Reinisch W, Zanger UM, Schwab M (2006) Three novel thiopurine S methyltransferase allelic variants (TPMT*20, *21, *22)—association with decreased enzyme function. Hum Mutat 27(9):976

    Article  PubMed  Google Scholar 

  8. Yates CR, Krynetski EY, Loennechen T, Fessing MY, Tai HL, Pui CH, Relling MV, Evans WE (1997) Molecular diagnosis of thiopurine S-methyl transferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med 126(8):608–614

    PubMed  CAS  Google Scholar 

  9. McLeod HL, Coulthard S, Thomas AE, Pritchard SC, King DJ, Richards SM, Eden OB, Hall AG, Gibson BE (1999) Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia. Br J Haematol 105(3):696–700

    Article  PubMed  CAS  Google Scholar 

  10. Tai HL, Krynetski EY, Yates CR, Loennechen T, Fessing MY, Krynetskaia NF, Evans WE (1996) Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent variant allele associated with loss of catalytic activity in Caucasians. Am J Hum Genet 58(4):694–702

    PubMed  CAS  Google Scholar 

  11. Coulthard SA, Howell C, Robson J, Hall AG (1998) The relationship between thiopurine methyltransferase activity and genotype in blasts from patients with acute leukemia. Blood 92(8):2856–2862

    PubMed  CAS  Google Scholar 

  12. Zhou S (2006) Clinical pharmacogenomics of thiopurine S-methyltransferase. Curr Clin Pharmacol 1(1):119–128

    PubMed  CAS  Google Scholar 

  13. Spire-Vayron de la Moureyre C, Debuysere H, Mastain B, Vinner E, Marez D, Lo Guidice JM, Chevalier D, Brique S, Motte K, Colombel JF, Turck D, Noel C, Flipo RM, Pol A, Lhermitte M, Lafitte JJ, Libersa C, Broly F (1998) Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in a European population. Br J Pharmacol 125(4):879–887

    Article  PubMed  CAS  Google Scholar 

  14. McLeod HL, Pritchard SC, Githang’a J, Indalo A, Ameyaw MM, Powrie RH, Booth L, Collie-Duguid ES (1999) Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals. Pharmacogenetics 9(6):773–776

    Article  PubMed  CAS  Google Scholar 

  15. Hon YY, Fessing MY, Pui CH, Relling MV, Krynetski EY, Evans WE (1999) Polymorphism of the thiopurine S-methyltransferase gene in African-Americans. Hum Mol Genet 8:371–376

    Article  PubMed  CAS  Google Scholar 

  16. Ameyaw MM, Collie-Duguid ES, Powrie RH, Ofori-Adjei D, McLeod HL (1999) Thiopurine methyltransferase alleles in British and Ghanaian populations. Hum Mol Genet 8(2):371–376

    Article  Google Scholar 

  17. Rossi AM, Bianchi M, Guarnieri C, Barale R, Pacifici GM (2001) Genotype-phenotype correlation for thiopurine S-methyltransferase in healthy Italian subjects. Eur J Clin Pharmacol 57(1):51–54

    Article  PubMed  CAS  Google Scholar 

  18. Hiratsuka M, Inoue T, Omori F, Agatsuma Y, Mizugaki M (2000) Genetic analysis of thiopurine methyltransferase polymorphism in a Japanese population. Mutat Res 448(1):91–95

    Article  PubMed  CAS  Google Scholar 

  19. Chang JG, Lee LS, Chen CM, Shih MC, Wu MC, Tsai FJ, Liang DC (2002) Molecular analysis of thiopurine S-methyltransferase alleles in South–east Asian populations. Pharmacogenetics 12(3):191–195

    Article  PubMed  CAS  Google Scholar 

  20. Kham SK, Tan PL, Tay AH et al (2002) Thiopurine methyltransferase polymorphisms in a multiracial Asian population and children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol 24:353–359

    Article  PubMed  CAS  Google Scholar 

  21. Larovere LE, De Kremer RD, Lambooy LH, De Abreu RA (2003) Genetic polymorphism of thiopurine S-methyltransferase in Argentina. Ann Clin Biochem 40:388–393

    Article  PubMed  CAS  Google Scholar 

  22. Isaza C, Henao J, Lopez AM, Cacabelos R (2003) Allelic variants of the thiopurine methyltransferase (TPMT) gene in the Colombian population. Methods Find Exp Clin Pharmacol 25:423–429

    Article  PubMed  CAS  Google Scholar 

  23. Momeni DA (1975) In: the Population of Iran: a dynamic analysis. Pahlavi University Publication, Shiraz

    Google Scholar 

  24. Boulonois I (1966) In: the silk road. Allen & Unwin, London

    Google Scholar 

  25. Al-Taie A (2000) Ethnic identity crisis in Iran. Shadegan publication, Tehran, pp 167–170

    Google Scholar 

  26. Farjadian S, Ghaderi A (2007) HLA class II genetic diversity in Arabs and Jews of Iran. Iran J Immunol 4(2):85–93

    PubMed  Google Scholar 

  27. Farjadian S, Naruse T, Kawata H, Ghaderi A, Bahram S, Inoko H (2004) Molecular analysis of HLA allele frequencies and haplotypes in Baloch of Iran compared with related populations of Pakistan. Tissue Antigens 64:581–587

    Article  PubMed  CAS  Google Scholar 

  28. Ashouri E, Farjadian S, Reed EF, Ghaderi A, Rajalingam R (2009) KIR gene content diversity in four Iranian populations. Immunogenetics 61(7):483–492

    Article  PubMed  CAS  Google Scholar 

  29. Farjadian S, Ota M, Inoko H, Ghaderi A (2009) The genetic relationship among Iranian ethnic groups: an anthropological view based on HLA class II gene polymorphism. Mol Biol Rep 36(7):1943–1950

    Article  PubMed  CAS  Google Scholar 

  30. Faghih Z, Erfani N, Razmkhah M, Sameni S, Talei A, Ghaderi A (2009) Interleukin-13 haplotypes and susceptibility of Iranian women to breast cancer. Mol Biol Rep 36(7):1923–1928

    Article  PubMed  CAS  Google Scholar 

  31. Aghdaie MH, Azarpira N, Kazemi K, Geramizadeh B, Darai M, Malekhoseini SA (2011) Frequency of HLA-G exon 8 polymorphisms and kidney allograft outcome in Iranian population. Mol Biol Rep 38(5):3593–3597

    Article  PubMed  CAS  Google Scholar 

  32. Azarpira N, Ashraf MJ, Khademi B, Darai M, Hakimzadeh A, Abedi E (2011) Study the polymorphism of CYP3A5 and CYP3A4 loci in Iranian population with laryngeal squamous cell carcinoma. Mol Biol Rep Mar 6, [Epub ahead of print]

  33. Namvaran F, Rahimi-Moghaddam P, Azarpira N, Nikeghbalian S (2011) The association between adiponectin (+45T/G) and adiponectin receptor-2 (+795G/A) single nucleotide polymorphisms with cirrhosis in Iranian population. Mol Biol Rep Jun 25, [Epub ahead of print]

  34. Sameni S, Ghayumi MA, Mortazavi G, Faghih Z, Kashef MA, Ghaderi A (2009) Lack of association between interleukin-13 gene polymorphisms (−1055 C/T and +2044 G/A) in Iranian patients with lung cancer. Mol Biol Rep 36(5):1001–1005

    Article  PubMed  CAS  Google Scholar 

  35. Senemar S, Doroudchi M, Pezeshki AM, Bazrgar M, Torab-Jahromi A, Ghaderi A (2009) Frequency of cystathionine beta-synthase 844INS68 polymorphism in Southern Iran. Mol Biol Rep 36(2):353–356

    Article  PubMed  CAS  Google Scholar 

  36. Mohamadynejad P, Saadat M (2008) Genetic polymorphisms of XRCC1 (at codons 194 and 399) in Shiraz population (Fars province, southern Iran). Mol Biol Rep 35(4):669–672

    Article  PubMed  CAS  Google Scholar 

  37. Bazrgar M, Karimi M, Fathzadeh M, Senemar S, Peiravian F, Shojaee A, Saadat M (2008) Apolipoprotein E polymorphism in Southern Iran: E4 allele in the lowest reported amounts. Mol Biol Rep 35(4):495–499

    Article  PubMed  CAS  Google Scholar 

  38. Esteghamati A, Mansournia N, Nakhjavani M, Mansournia MA, Nikzamir A, Abbasi M (2011) Association of +45(T/G) and +276(G/T) polymorphisms in the adiponectin gene with coronary artery disease in a population of Iranian patients with type 2 diabetes. Mol Biol Rep Jul 10, [Epub ahead of print]

  39. Mohammadnejad Z, Ghanbari M, Ganjali R, Afshari JT, Heydarpour M, Taghavi SM, Fatemi S, Rafatpanah H (2011) Association between vitamin D receptor gene polymorphisms and type 1 diabetes mellitus in Iranian population. Mol Biol Rep May 17, [Epub ahead of print]

  40. Kordi-Tamandani DM, Hashemi M, Sharifi N, Kaykhaei MA, Torkamanzehi A (2011) Association between paraoxonase-1 gene polymorphisms and risk of metabolic syndrome. Mol Biol Rep May 15, [Epub ahead of print]

  41. Hedayati M, Sharifi K, Rostami F, Daneshpour MS, Zarif Yeganeh M, Azizi F (2011) Association between TNF-α promoter G-308A and G-238A polymorphisms and obesity. Mol Biol Rep May 11, [Epub ahead of print]

  42. Nafissi S, Saadat I, Saadat M (2011) Genetic polymorphisms of glutathione S-transferase Z1 in an Iranian population. Mol Biol Rep 38(5):3391–3394

    Article  PubMed  CAS  Google Scholar 

  43. Nasidze I, Quinque D, Rahmani M, Alemohamad SA, Stoneking M (2008) Close genetic relationship between Semitic-speaking and Indo-European-speaking groups in Iran. Ann Hum Genet 72(Pt 2):241–252

    Article  PubMed  CAS  Google Scholar 

  44. Mladosievicova B, Dzurenkova A, Sufliarska S, Carter A (2011) Clinical relevance of thiopurine S-methyltransferase gene polymorphisms. Neoplasma 58(4):277–282

    Article  PubMed  CAS  Google Scholar 

  45. Nguyen CM, Mendes MA, Ma JD (2011) Thiopurine methyltransferase (TPMT) genotyping to predict myelosuppression risk. PLoS Curr 3:RRN1236

    Article  PubMed  Google Scholar 

  46. Connell WR, Kamm MA, Ritchie JK et al (1993) Bone marrow toxicity caused by azathioprine inflammatory bowel disease: 27 years of experience. Gut 34:1081–1085

    Article  PubMed  CAS  Google Scholar 

  47. Korbluth A, Sachar DB, The Practice Parameters Committee of the American College of Gastroenterology (2010) Erratum: ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Ams J Gastroenterol 105:500–523

    Article  Google Scholar 

  48. Stojiljkovic M, Patrinos GP, Pavlovic S (2011) Clinical applicability of sequence variations in genes related to drug metabolism. Curr Drug Metab 12(5):445–454

    Article  PubMed  CAS  Google Scholar 

  49. Tumer TB, Ulusoy G, Adali O, Sahin G, Gozdasoglu S, Arinç E (2007) The low frequency of defective TPMT alleles in Turkish population: a study on pediatric patients with acute lymphoblastic leukemia. Am J Hematol 82(10):906–910

    Article  PubMed  CAS  Google Scholar 

  50. Hakooz N, Arafat T, Payne D, Ollier W, Pushpakom S, Andrews J, Newman W (2010) Genetic analysis of thiopurine methyltransferase polymorphism in the Jordanian population. Eur J Clin Pharmacol 66(10):999–1003

    Article  PubMed  CAS  Google Scholar 

  51. Samochatova EV, Chupova NV, Rudneva A, Makarova O, Nasedkina TV, Fedorova OE, Glotov AS, Kozhekbaeva Zh, Maiorova OA, Roumyantsev AG, Krynetski EY, Krynetskaia NF, Evans WE, Ribeiro RC (2009) TPMT genetic variations in populations of the Russian Federation. Pediatr Blood Cancer 52(2):203–208

    Article  PubMed  Google Scholar 

  52. Bahari A, Hashemi M, Bari Z, Moazeni-Roodi A, Kaykhaei MA, Narouie B (2010) Frequency of thiopurine S-methyltransferase (TPMT) alleles in southeast Iranian population. Nucleosides Nucleotides Nucleic Acids 29(3):237–244

    Article  PubMed  CAS  Google Scholar 

  53. Azad M, Kaviani S, Soleimani M, Noruzinia M, Hajfathali A (2009) Common polymorphism’s analysis of thiopurine S-methyltransferase (TPMT) in Iranian population. Yakhteh Med J 11(3):311–316

    CAS  Google Scholar 

  54. Azarpira N, Namazi S, Hendijani F, Banan M, Darai M (2010) Investigation of allele and genotype frequencies of CYP2C9, CYP2C19 and VKORC1 in Iran. Pharmacol Rep 62(4):740–746

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Negar Azarpira.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moini, M., Ghaderi, F., Sagheb, M.M. et al. The frequency and distribution of thiopurine S-methyltransferase alleles in south Iranian population. Mol Biol Rep 39, 4581–4587 (2012). https://doi.org/10.1007/s11033-011-1248-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-011-1248-6

Keywords

Navigation